Forty years ago men landed on, and walked on, the moon.
20 August, 2009
The European Commission has approved the Marketing Authorisation Application for Otsuka's oral once-daily medication Samsca™ (tolvaptan), a selective V2-vasopressin receptor antagonist, for the treatment of hyponatraemia secondary to SIADH in adults.
04 August, 2009